BD Ultra-Fine Insulin Syringes Recalled Due to Nonsterile Condition
Becton Dickinson is recalling BD Ultra-Fine Insulin Syringes (Catalog Number 326719) due to a nonsterile condition that could expose patients to pathogenic microorganisms and local infection. Approximately 80,500 units distributed worldwide are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving a nonsterile medical device designed for insulin administration. The nonsterile condition poses a risk of infection from pathogenic microorganisms. No illnesses or injuries are reported in the source material, but the risk-of-harm nature of the product warrants a High severity classification per the rubric.
Plain-English summary
Becton Dickinson & Company is recalling BD Ultra-Fine Insulin Syringes (1mL, 12.7mm, 29G, Catalog Number 326719) due to a nonsterile condition. These syringes are designed for administering insulin in diabetes treatment. The nonsterile condition creates a potential risk of exposure to pathogenic microorganisms and local infection.
The recall involves Lot Number 2031581, totaling approximately 80,500 units distributed worldwide. Distribution includes the United States and the following countries: Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, and Canada.
The recalled product
- Product
- BD Ultra-Fine Insulin Syringe 1mL, 12.7mm, 29G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326719
- Manufacturer
- Becton Dickinson & Company
- Affected units
- 80,500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- GTIN: N/A Lot Number: 2031581
- Exp. Date: 2031581
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Becton Dickinson & Company under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Company
See all →- SevereBD Quincke spinal trays recalled over Huons bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 24 gauge spinal trays recalled over bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD combined Whitacre and Quincke spinal trays recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD Whitacre spinal trays across nine catalog numbers recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 22G spinal trays recalled in Huons bupivacaine sub-recall
FDA (Devices) · 2026-06-10
Same hazard · nonsterile
See all →- HighBD Ultra-Fine Insulin Syringe Recall Due to Nonsterile Manufacturing
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled for Sterility Defect
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled for Nonsterile Condition and Infection Risk
FDA (Devices) · 2023-03-22
- HighBD Ultra-Fine Insulin Syringe 0.5mL Recalled for Nonsterility Risk
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled Due to Nonsterile Condition
FDA (Devices) · 2023-03-22